Skip to content
OpenCapital
Get started

Celldex Therapeutics CLDX Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Pfizer logo
PfizerPFE
$159.73B+11.1%
Rogers Corporation logo
Rogers CorporationROG
$1.91B+53.1%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Incyte logo
IncyteINCY
$18.73B+59.9%

Other financials

Income statement

See full
Revenue$15.0K-97.8%
Operating income-$84.4M-34.6%
Net income-$78.7M-46.3%
EPS (diluted)-$1.18-45.7%

Balance sheet

See full
Cash & equivalents$35.7M+109%
Total debt$1.9M-44.3%
Total equity$456.2M-35.1%
Total assets$511.3M-30.9%

Cash flow

See full
Operating cash flow-$65.6M-20.6%
CapEx$1.6M+518%
Free cash flow-$67.2M-23.0%

Valuation

See full
Enterprise value$2.55B+74.4%
P/S2,989.2×+2,794×

Profitability

See full
Operating margin-35,688.5%-39,114pp
Net margin-32,753.6%-35,519pp
FCF margin-26,125.8%-28,907pp

Returns & leverage

See full
Return on equity-48.9%-498pp
Debt / equity0×0.0×
Current ratio8.9×-12.7×

Where this comes from

Computed from the period-end share price: $2.11B.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celldex Therapeutics's market capitalization?
Celldex Therapeutics (CLDX) reported market capitalization of $2.11B in Q1 2026.
How has Celldex Therapeutics's market capitalization changed year-over-year?
Celldex Therapeutics's market capitalization increased by 75.2% year-over-year, from $1.2B to $2.11B.
What is the long-term trend for Celldex Therapeutics's market capitalization?
Over 5 years (2020 to 2025), Celldex Therapeutics's market capitalization has grown at a 17.2% compound annual growth rate (CAGR), from $817.55M to $1.8B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.